期刊文献+

罗哌卡因复合舒芬太尼腰-硬联合阻滞用于分娩镇痛50例 被引量:2

原文传递
导出
摘要 目的研究罗哌卡因复合舒芬太尼腰-硬联合阻滞(CSEA)用于分娩镇痛的临床效果和可行性。方法 100例孕足月初产妇,罗哌卡因复合舒芬太尼CSEA镇痛产妇50例作为研究组,自然分娩50例作为对照组,应用视觉模拟痛觉评分法(VAS)和运动神经阻滞程度(Bromage)分级法评价镇痛效果,比较2组产妇产程、胎儿情况及失血量等临床指标。结果与对照组相比,罗哌卡因复合舒芬太尼CSEA镇痛效果显著(痛觉评分有效率96.0%vs10.0%,P<0.01),副作用少,第一产程明显缩短(P<0.01),失血量减少〔(150±80)vs(215±92)ml,P<0.01〕;中转剖宫产率及Apgar评分与对照组比较差异无统计学意义(P均>0.05)。结论罗哌卡因复合舒芬太尼CSEA是理想的分娩镇痛手段,具有镇痛快、效果好、使用安全等优点。
作者 李云
出处 《中国临床研究》 CAS 2011年第7期597-598,共2页 Chinese Journal of Clinical Research
  • 相关文献

参考文献6

  • 1Richardson MG. Regional anesthesia for obstetrics[J]. Anelgthesiol Clin North America,2000,18 (2) :383 - 406.
  • 2Conell-Priee J, Evans JB, Hong D, et sl. The development and vali- dation of a dynamic model to account for the progress of labor in the assessment of pain [J]. Anesth Analg,2008,106 ( 5 ) : 1509 - 1515.
  • 3Braneato BM, Church S, Stone PW. A meta-analysis of passive de- scent versus immediate pushing in nulliparous women with epidural analgesia in the second stage of labor[J].J Obstet Gynecol Neonatal Nurs,2008,37 ( 1 ) :4 - 12.
  • 4Minty RG, Kelly L, Minty A, et al. Single-dose intrathecal analgesia to control labour pain: is it a useful alternative to epidural analgesia? [J].Can Fam Physician,2007,53 ( 3 ) :437 - 442.
  • 5曹国平.无痛分娩术中行走对产程的影响[J].临床麻醉学杂志,2009,25(8):718-718. 被引量:1
  • 6罗小玲,陈世彪.分娩镇痛对产妇血Th1/Th2型细胞因子平衡的影响[J].临床麻醉学杂志,2009,25(7):603-605. 被引量:10

二级参考文献13

  • 1肖云山,林其德.妊娠早期蜕膜组织巨噬细胞分泌IL-10/IFN-γ功能的特征[J].现代妇产科进展,2005,14(3):218-221. 被引量:12
  • 2Furuta I, Yamada H, Sagawa T, et al. Effects of inflammatory cytokines on prostaglandin E (2) production from human amnion cells cultured in serum free condition. Gynecol Obstet Invest, 2000, 49:93-97.
  • 3Haddad J J, Saade NE, Safieh-Garabedian B. Cytokine and neuro-immune-endocrine interactions: a role for the hypothalamie-pituitary-adrenal revolving axis. J Neuroimmunol, 2002, 133:11-19.
  • 4Bennett WA, Lagoo-Deenadayalan S, Whitworth NS, et al. Expression and production of interleukin-10 by human trophoblast:relationship to pregnancy immunotolerance. Early Pregnancy, 1997, 3:190-198.
  • 5Pomini F, Caruso A, Challis JR. Interleukin-10 modifies the effects of interleukin-1beta and tumor necrosis faetor-alpha on the activity and expression of prostaglandin Hsynthase-2 and the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and ehorion trophoblast cells. J Clin Enderinol Metab, 1999, 84:4645-4651.
  • 6Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology, 2001, 103:131-136.
  • 7Asadullsh K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev,2003, 55: 241-269.
  • 8Nguyen KT, Deak T, Will MJ, et al. Time course and corticosterone sensitivity of the brain, pituitary, and serum interleukin-tbeta protein response to acute stress. Brain Res, 2000, 859:193-201.
  • 9Turner MA, Shaikh SA, Greenwood SL. Secretion of interleukin- 1beta and interleukin-6 by fragments of term human placental villi: signalling pathways and effects of tumour necrosis factor alpha and mode of delivery. Placenta, 2002, 23:467-474.
  • 10Rechandson MG. Regional anesthesia for obstetrics. Aneshesiol Clin North Americia, 2000,18: 385-405.

共引文献9

同被引文献28

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部